no human schedule of any kind has been established
Human Safety Data Is Minimal A tiny 2025 pilot study testing IV BPC-157 up to 20 mg in 2 healthy adults found it well tolerated with no adverse events and no biomarker changes, but 2 subjects provide essentially zero statistical power
Ehud Ur, an endocrinologist in Vancouver who was not involved in the study, said the results are credible and that Health Canada's approval of Ozempic to help prevent kidney decline is "great news." "The prevention of kidney disease is a very important goal in the management of patients with Type 2 diabetes and this is another tool," said Ur, who is a professor of endocrinology and metabolism at the University of British Columbia
Establishing that it is requires a selective kinase inhibitor, a blocking antibody, a receptor-null or knockdown background, or at minimum a parallel insulin comparison, and a large amount of published and unpublished work on this compound does not include any of those
The most frequently reported ocular conditions were cataract, macular degeneration, and glaucoma